News and Events

News and Events 2018-05-21T15:12:34+00:00

June 2018        GMDx will be attending ASCO2018 in Chicago, IL.


April 2018        GMDx receives an “Innovation Connections” grant from the Department of Industry, Innovation and Science.

This grant is being used to support a staff member placement with the Hudson Institute of Medical Research to conduct further in vitro work on deaminase profiles.


April 2018        Key Patent Granted in Hong Kong

Title: “Methods for determining the cause of somatic mutagenesis”


Mar 2018         GMDx attended the City of Melbourne Trade Mission to Osaka, Japan.

GMDx attendees met with senior executives from some of Japan’s largest pharmaceutical companies and also with key collaborators at a number of world-class clinical institutions.


Feb 2018          GMDx attended the Molecular Medicine Tri-Con in San Francisco, February 2018.


Feb 2018          Dr Robyn Lindley invited to speak at “Eradicate Cancer 2018” Conference in Melbourne (abstract).


Jan 2018          Key Patent Granted in Japan

Title: “Methods for determining the cause of somatic mutagenesis”


Dec 2017         Key Patent Granted in Europe

Title: “Methods for determining the cause of somatic mutagenesis”


Sep 2017          Appointment of bioinformatician Jared Mamrot to the GMDx team


Aug 2017         GMDx receives an “Accelerating Commercialisation” Grant from the Department of Industry, Innovation and Science.

The grant is in support of a clinical trial for Hepatitis B treatment.


Jul 2017           Colorectal Clinical Study – Cabrini Hospital Melbourne

This planned study has received Ethics Committee Approval.


May 2017        GMDx attended the Biomarkers in Immuno-Oncology Congress in Philadelphia, PA.


Oct 2016          Robyn Lindley awarded the R. Douglas Wright medal and presented the oration titled:

The Hunt for the Source of Mutations in Cancer: A story of discovery and innovation at the coalface